1. Home
  2. AQN vs CPRX Comparison

AQN vs CPRX Comparison

Compare AQN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algonquin Power & Utilities Corp.

AQN

Algonquin Power & Utilities Corp.

HOLD

Current Price

$5.49

Market Cap

4.5B

Sector

Utilities

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.45

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQN
CPRX
Founded
1988
2002
Country
Canada
United States
Employees
3786
182
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.9B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
AQN
CPRX
Price
$5.49
$31.45
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$6.66
$35.00
AVG Volume (30 Days)
3.9M
1.8M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
4.22%
N/A
EPS Growth
N/A
28.24
EPS
N/A
0.50
Revenue
N/A
$119,072,803.00
Revenue This Year
$4.87
$9.20
Revenue Next Year
$5.02
$10.51
P/E Ratio
N/A
$62.94
Revenue Growth
N/A
16.39
52 Week Low
$5.32
$19.05
52 Week High
$7.11
$32.56

Technical Indicators

Market Signals
Indicator
AQN
CPRX
Relative Strength Index (RSI) 30.79 70.75
Support Level $5.39 $31.25
Resistance Level $6.08 $32.56
Average True Range (ATR) 0.14 0.04
MACD -0.04 -0.08
Stochastic Oscillator 6.35 75.00

Price Performance

Historical Comparison
AQN
CPRX

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units: the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution, and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: